Koninklijke DSM N.V.
KDSKF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $23 | $39 | $66 | $49 |
| - Cash | $2 | $3 | $2 | $1 |
| + Debt | $3 | $3 | $3 | $4 |
| Enterprise Value | $24 | $39 | $68 | $52 |
| Revenue | $8 | $8 | $9 | $8 |
| % Growth | -9.5% | -8.8% | 13.5% | – |
| Gross Profit | $2 | $3 | $3 | $3 |
| % Margin | 20.7% | 32.1% | 34.4% | 34.2% |
| EBITDA | $0 | $1 | $1 | $1 |
| % Margin | 4% | 16.4% | 15.2% | 17.7% |
| Net Income | $2 | $2 | $2 | $1 |
| % Margin | 30.5% | 20.3% | 18.2% | 6.2% |
| EPS Diluted | 13.38 | 9.77 | 9.63 | 2.89 |
| % Growth | 36.9% | 1.5% | 233.2% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | $0 | $0 | $1 | $1 |